Skip to main content
SpringerLink
Log in

Diet and Exercise Are Potent Modulators of Cardiovascular Disease in Women

  • Chapter
  • First Online:
Integrative Biology of Women’s Health

  • 782 Accesses

Abstract

Cardiovascular disease (CVD) is the number one killer of women in developed countries and its incidence is increasing in women in developing nations (Gholizadeh and Davidson, Health Care Women Int 29:3–22, 2008; Mosca et al., Circulation 123:1243–1262, 2011). Many factors influence a woman’s likelihood of developing CVD throughout her lifetime. These include intrinsic variables such as genetic background, hormonal status, and age as well as extrinsic variables such as smoking, diet, and level of physical activity. While the potential for intervention regarding the intrinsic factors can be limited and challenging, women can have a lot of control over the extrinsic factors, which may ultimately influence cardiovascular health more powerfully than pharmacologic interventions and can potentially counteract genetic predisposition (Stampfer et al., N Engl J Med 343:16–22, 2000).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gholizadeh L, Davidson P (2008) More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int 29:3–22

    PubMed  Google Scholar 

  2. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pina IL, Roger VL, Shaw LJ et al (2011) Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American heart association. Circulation 123:1243–1262

    PubMed  Google Scholar 

  3. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343:16–22

    CAS  PubMed  Google Scholar 

  4. Ford ES, Capewell S (2007) Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50:2128–2132

    PubMed  Google Scholar 

  5. Mensah GA, Brown DW, Croft JB, Greenlund KJ (2005) Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Prev Med 29:68–74

    PubMed  Google Scholar 

  6. Page IH, Stare FJ, Corcoran AC, Pollack H, Wilkinson CF Jr (1957) Atherosclerosis and the fat content of the diet. Circulation 16:163–178

    CAS  PubMed  Google Scholar 

  7. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, Pasternak R, Pearson TA, Redberg RF, Smith SC Jr et al (1999) Guide to preventive cardiology for women.AHA/ACC scientific statement consensus panel statement. Circulation 99:2480–2484

    CAS  PubMed  Google Scholar 

  8. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN (2000) Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American heart association women’s heart disease and stroke campaign task force. Arch Fam Med 9:506–515

    CAS  PubMed  Google Scholar 

  9. Mosca L, Ferris A, Fabunmi R, Robertson RM (2004) Tracking women’s awareness of heart disease: an American Heart Association National Study. Circulation 109:573–579

    PubMed  Google Scholar 

  10. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL et al (2006) Low-fat dietary pattern and risk of cardiovascular disease: the women’s health initiative randomized controlled dietary modification trial. JAMA 295:655–666

    CAS  PubMed  Google Scholar 

  11. Prentice RL, Anderson GL (2008) The women’s health initiative: lessons learned. Annu Rev Public Health 29:131–150

    PubMed  Google Scholar 

  12. Joshipura KJ, Hung HC, Li TY, Hu FB, Rimm EB, Stampfer MJ, Colditz G, Willett WC (2009) Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr 12:115–121

    PubMed  Google Scholar 

  13. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH, Manson JE (2000) A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71:1455–1461

    CAS  PubMed  Google Scholar 

  14. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH, Willett WC (1999) Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health Study. Am J Clin Nutr 70:412–419

    CAS  PubMed  Google Scholar 

  15. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH (1988) A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319:267–273

    CAS  PubMed  Google Scholar 

  16. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC (2005) Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses’ Health study. Am J Epidemiol 161:672–679

    PubMed  Google Scholar 

  17. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341:581–585

    CAS  PubMed  Google Scholar 

  18. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287:1815–1821

    CAS  PubMed  Google Scholar 

  19. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB (2005) Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 112:3232–3238

    CAS  PubMed  Google Scholar 

  20. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359–364

    CAS  PubMed  Google Scholar 

  21. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444–1449

    CAS  PubMed  Google Scholar 

  22. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, Willett WC (2003) Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 42:246–252

    CAS  PubMed  Google Scholar 

  23. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS et al (2012) Heart disease and stroke statistics–2012 update: a report from the American heart association. Circulation 125:e2–e220

    PubMed  Google Scholar 

  24. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM et al (2002) AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106:388–391

    PubMed  Google Scholar 

  25. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82–96

    PubMed  Google Scholar 

  26. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M (2006) Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113:1034–1044

    CAS  PubMed  Google Scholar 

  27. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109:2705–2711

    PubMed  Google Scholar 

  28. Harris WS (1997) n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65:1645S–1654S

    CAS  PubMed  Google Scholar 

  29. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112:1945–1952

    CAS  PubMed  Google Scholar 

  30. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20:1493–1499

    CAS  PubMed  Google Scholar 

  31. Mozaffarian D, Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58:2047–2067

    CAS  PubMed  Google Scholar 

  32. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:757–761

    CAS  PubMed  Google Scholar 

  33. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 354:447–455

    Google Scholar 

  34. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP et al (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903

    CAS  PubMed  Google Scholar 

  35. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H et al (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369:1090–1098

    CAS  PubMed  Google Scholar 

  36. Meydani M, Natiello F, Goldin B, Free N, Woods M, Schaefer E, Blumberg JB, Gorbach SL (1991) Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 121:484–491

    CAS  PubMed  Google Scholar 

  37. Ciubotaru I, Lee YS, Wander RC (2003) Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 14:513–521

    CAS  PubMed  Google Scholar 

  38. Laidlaw M, Holub BJ (2003) Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 77:37–42

    CAS  PubMed  Google Scholar 

  39. Stark KD, Park EJ, Maines VA, Holub BJ (2000) Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am J Clin Nutr 72:389–394

    CAS  PubMed  Google Scholar 

  40. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE (2003) Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107:1852–1857

    PubMed  Google Scholar 

  41. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 66:649–659

    CAS  PubMed  Google Scholar 

  42. Kris-Etherton PM, Harris WS, Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757

    PubMed  Google Scholar 

  43. Law MR, Wald NJ, Thompson SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308:367–372

    CAS  PubMed  Google Scholar 

  44. Law M (2000) Plant sterol and stanol margarines and health. BMJ 320:861–864

    CAS  PubMed  Google Scholar 

  45. Dempsey ME, Farquhar JW, Smith RE (1956) The effect of beta sitosterol on the serum lipids of young men with arteriosclerotic heart disease. Circulation 14:77–82

    CAS  PubMed  Google Scholar 

  46. Heinemann T, Leiss O, von Bergmann K (1986) Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 61:219–223

    CAS  PubMed  Google Scholar 

  47. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E (1995) Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333:1308–1312

    CAS  PubMed  Google Scholar 

  48. Gylling H, Radhakrishnan R, Miettinen TA (1997) Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 96:4226–4231

    CAS  PubMed  Google Scholar 

  49. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, Karmally W, Sikand G (2008) The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 108:287–331

    PubMed  Google Scholar 

  50. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R et al (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:523–534

    CAS  PubMed  Google Scholar 

  51. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465–1477

    CAS  PubMed  Google Scholar 

  52. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276–282

    CAS  PubMed  Google Scholar 

  53. Crouse JR 3rd, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070–2076

    CAS  PubMed  Google Scholar 

  54. Weggemans RM, Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57:940–946

    CAS  PubMed  Google Scholar 

  55. Yeung J, Yu TF (2003) Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2:15

    PubMed  Google Scholar 

  56. Dewell A, Hollenbeck CB, Bruce B (2002) The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 87:118–121

    CAS  PubMed  Google Scholar 

  57. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292:65–74

    CAS  PubMed  Google Scholar 

  58. Cassidy A, Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y, Wolk A et al (2006) Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 65:76–92

    CAS  PubMed  Google Scholar 

  59. Rios DR, Rodrigues ET, Cardoso AP, Montes MB, Franceschini SA, Toloi MR (2008) Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Nutrition 24:1153–1158

    CAS  PubMed  Google Scholar 

  60. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ (2008) Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. J Womens Health (Larchmt) 17:1363–1369

    Google Scholar 

  61. Erdman JW Jr (2000) AHA science advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 102:2555–2559

    CAS  PubMed  Google Scholar 

  62. Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344:793–795

    CAS  PubMed  Google Scholar 

  63. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724

    CAS  PubMed  Google Scholar 

  64. Ceconi C, Boraso A, Cargnoni A, Ferrari R (2003) Oxidative stress in cardiovascular disease: myth or fact? Arch Biochem Biophys 420:217–221

    CAS  PubMed  Google Scholar 

  65. Dauchet L, Amouyel P, Hercberg S, Dallongeville J (2006) Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 136:2588–2593

    CAS  PubMed  Google Scholar 

  66. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J (1998) Vitamin C exhibits pro-oxidant properties. Nature 392:559

    CAS  PubMed  Google Scholar 

  67. Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr (2004) Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 80:1194–1200

    CAS  PubMed  Google Scholar 

  68. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE (2007) A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study. Arch Intern Med 167:1610–1618

    CAS  PubMed  Google Scholar 

  69. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA 294:56–65

    CAS  PubMed  Google Scholar 

  70. Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S et al (2004) Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80:1508–1520

    CAS  PubMed  Google Scholar 

  71. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334:1156–1162

    CAS  PubMed  Google Scholar 

  72. de Gaetano G (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357:89–95

    PubMed  Google Scholar 

  73. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J et al (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347

    PubMed  Google Scholar 

  74. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46

    CAS  PubMed  Google Scholar 

  75. Dietrich M, Traber MG, Jacques PF, Cross CE, Hu Y, Block G (2006) Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J Am Coll Nutr 25:292–299

    CAS  PubMed  Google Scholar 

  76. Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA (1985) Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr 115:807–813

    CAS  PubMed  Google Scholar 

  77. Bowry VW, Stocker R (1993) Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. JACS 115:6029–6044

    CAS  Google Scholar 

  78. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH (1999) Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women’s Health study. J Natl Cancer Inst 91:2102–2106

    CAS  PubMed  Google Scholar 

  79. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM et al (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145–1149

    CAS  PubMed  Google Scholar 

  80. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029–1035

    Google Scholar 

  81. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH et al (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155

    CAS  PubMed  Google Scholar 

  82. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592

    CAS  PubMed  Google Scholar 

  83. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164:2335–2342

    CAS  PubMed  Google Scholar 

  84. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH (1999) Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 281:1817–1821

    CAS  PubMed  Google Scholar 

  85. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288(16):2015–2022

    Google Scholar 

  86. Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JC, Stehouwer CD (2000) Increased plasma homocysteine after menopause. Atherosclerosis 149:163–168

    CAS  PubMed  Google Scholar 

  87. Mijatovic V, Kenemans P, Jakobs C, van Baal WM, Peters-Muller ER, van der Mooren MJ (1998) A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 91:432–436

    CAS  PubMed  Google Scholar 

  88. van Baal WM, Smolders RG, van der Mooren MJ, Teerlink T, Kenemans P (1999) Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 94:485–491

    PubMed  Google Scholar 

  89. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C et al (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567–1577

    CAS  PubMed  Google Scholar 

  90. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578–1588

    CAS  PubMed  Google Scholar 

  91. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 299:2027–2036

    CAS  PubMed  Google Scholar 

  92. Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483–492

    CAS  PubMed  Google Scholar 

  93. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511

    CAS  PubMed  Google Scholar 

  94. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373

    CAS  PubMed  Google Scholar 

  95. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, Ragi-Eis S, Chandler J (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260:245–254

    CAS  PubMed  Google Scholar 

  96. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR (1999) Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 149:151–161

    CAS  PubMed  Google Scholar 

  97. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S et al (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–854

    CAS  PubMed  Google Scholar 

  98. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J et al (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33:159–171

    CAS  PubMed  Google Scholar 

  99. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526

    CAS  PubMed  Google Scholar 

  100. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341:454–457

    CAS  PubMed  Google Scholar 

  101. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235:207–219

    CAS  PubMed  Google Scholar 

  102. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ (2000) Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 47:549–555

    CAS  PubMed  Google Scholar 

  103. Pignatelli P, Ghiselli A, Buchetti B, Carnevale R, Natella F, Germano G, Fimognari F, Di Santo S, Lenti L, Violi F (2006) Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188:77–83

    CAS  PubMed  Google Scholar 

  104. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342

    CAS  PubMed  Google Scholar 

  105. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, Willett WC, Manson JE (2000) Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494–499

    CAS  PubMed  Google Scholar 

  106. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willett WC (1999) Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69:890–897

    CAS  PubMed  Google Scholar 

  107. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111:157–164

    CAS  PubMed  Google Scholar 

  108. Burdge G (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7:137–144

    CAS  PubMed  Google Scholar 

  109. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL (2004) Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr 80:1167–1174

    CAS  PubMed  Google Scholar 

  110. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B et al (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107:3109–3116

    PubMed  Google Scholar 

  111. Mole PA (1978) Increased contractile potential of papillary muscles from exercise-trained rat hearts. Am J Physiol 234:H421–H425

    CAS  PubMed  Google Scholar 

  112. Schaible TF, Scheuer J (1981) Cardiac function in hypertrophied hearts from chronically exercised female rats. J Appl Physiol 50:1140–1145

    CAS  PubMed  Google Scholar 

  113. Schaible TF, Penpargkul S, Scheuer J (1981) Cardiac responses to exercise training in male and female rats. J Appl Physiol 50:112–117

    CAS  PubMed  Google Scholar 

  114. Goldsmith RL, Bloomfield DM, Rosenwinkel ET (2000) Exercise and autonomic function. Coron Artery Dis 11:129–135

    CAS  PubMed  Google Scholar 

  115. Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA (1994) Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am Coll Cardiol 24:1700–1707

    CAS  PubMed  Google Scholar 

  116. Shephard RJ, Balady GJ (1999) Exercise as cardiovascular therapy. Circulation 99:963–972

    CAS  PubMed  Google Scholar 

  117. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554

    CAS  PubMed  Google Scholar 

  118. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S (1997) Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. JAMA 277:1281–1286

    CAS  PubMed  Google Scholar 

  119. Centers for Disease Control and Prevention (1996) Surgeon general’s report on physical activity and health. From the Centers for Disease Control and Prevention. JAMA 276:522

    Google Scholar 

  120. Meinert CL, Gilpin AK, Unalp A, Dawson C (2000) Gender representation in trials. Control Clin Trials 21:462–475

    CAS  PubMed  Google Scholar 

  121. Brunner D, Manelis G, Modan M, Levin S (1974) Physical activity at work and the incidence of myocardial infarction, angina pectoris and death due to ischemic heart disease. An epidemiological study in Israeli collective settlements (Kibbutzim). J Chronic Dis 27:217–233

    CAS  PubMed  Google Scholar 

  122. Salonen JT, Puska P, Tuomilehto J (1982) Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol 115:526–537

    CAS  PubMed  Google Scholar 

  123. Lapidus L, Bengtsson C (1986) Socioeconomic factors and physical activity in relation to cardiovascular disease and death. A 12 year follow up of participants in a population study of women in Gothenburg, Sweden. Br Heart J 55:295–301

    CAS  PubMed  Google Scholar 

  124. Kannel WB, Sorlie P (1979) Some health benefits of physical activity. The Framingham Study. Arch Intern Med 139:857–861

    CAS  PubMed  Google Scholar 

  125. Weller I, Corey P (1998) The impact of excluding non-leisure energy expenditure on the relation between physical activity and mortality in women. Epidemiology 9:632–635

    CAS  PubMed  Google Scholar 

  126. Swain DP, Franklin BA (2006) Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. Am J Cardiol 97:141–147

    PubMed  Google Scholar 

  127. Morris JN, Clayton DG, Everitt MG, Semmence AM, Burgess EH (1990) Exercise in leisure time: coronary attack and death rates. Br Heart J 63:325–334

    CAS  PubMed  Google Scholar 

  128. Department of Health and Human Services (1996) Physical activity and health: a report of the surgeon general. Atlanta, Georgia: USDHSS, Centers for Disease Control and Prevention

    Google Scholar 

  129. Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Speizer FE, Hennekens CH (1999) A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 341:650–658

    CAS  PubMed  Google Scholar 

  130. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE (2001) Physical activity and coronary heart disease in women: is “no pain, no gain” passe? JAMA 285:1447–1454

    CAS  PubMed  Google Scholar 

  131. Breslow RA, Ballard-Barbash R, Munoz K, Graubard BI (2001) Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Epidemiol Biomarkers Prev 10:805–808

    CAS  PubMed  Google Scholar 

  132. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR et al (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109:672–693

    PubMed  Google Scholar 

  133. Mark DB, Lauer MS (2003) Exercise capacity: the prognostic variable that doesn’t get enough respect. Circulation 108:1534–1536

    PubMed  Google Scholar 

  134. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801

    PubMed  Google Scholar 

  135. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ (2002) Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 106:666–671

    PubMed  Google Scholar 

  136. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ (2003) Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 42:2139–2143

    PubMed  Google Scholar 

  137. Ades PA, Balady GJ, Berra K (2001) Transforming exercise-based cardiac rehabilitation programs into secondary prevention centers: a national imperative. J Cardiopulm Rehabil 21:263–272

    CAS  PubMed  Google Scholar 

  138. Thomas RJ, Miller NH, Lamendola C, Berra K, Hedback B, Durstine JL, Haskell W (1996) National survey on gender differences in cardiac rehabilitation programs. Patient characteristics and enrollment patterns. J Cardiopulm Rehabil 17:402–412

    CAS  PubMed  Google Scholar 

  139. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, Certo CM, Dattilo AM, Davis D, DeBusk RF et al (1995) Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. Clin Pract Guidel Quick Ref Guide Clin:1–23

    Google Scholar 

  140. Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P (1997) Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur Heart J 18:664–670

    CAS  PubMed  Google Scholar 

  141. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB (1992) Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86:1099–1107

    CAS  PubMed  Google Scholar 

  142. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr (1988) Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 62:1–7

    CAS  PubMed  Google Scholar 

  143. Cannistra LB, Balady GJ, O’Malley CJ, Weiner DA, Ryan TJ (1992) Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol 69:1274–1279

    CAS  PubMed  Google Scholar 

  144. Ascensao A, Ferreira R, Magalhaes J (2007) Exercise-induced cardioprotection–biochemical, morphological and functional evidence in whole tissue and isolated mitochondria. Int J Cardiol 117:16–30

    PubMed  Google Scholar 

  145. Ross R, Janssen I (2001) Physical activity, total and regional obesity: dose–response considerations. Med Sci Sports Exerc 33:S521–S527, discussion S528–S529

    CAS  PubMed  Google Scholar 

  146. Fagard RH (2001) Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 33:S484–S492, discussion S493–S494

    CAS  PubMed  Google Scholar 

  147. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA (2004) American college of sports medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36:533–553

    PubMed  Google Scholar 

  148. Leon AS, Rice T, Mandel S, Despres JP, Bergeron J, Gagnon J, Rao DC, Skinner JS, Wilmore JH, Bouchard C (2000) Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study. Metabolism 49:513–520

    CAS  PubMed  Google Scholar 

  149. Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD (2001) Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 31:1033–1062

    CAS  PubMed  Google Scholar 

  150. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD et al (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483–1492

    CAS  PubMed  Google Scholar 

  151. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 109:433–438

    PubMed  Google Scholar 

  152. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS (1999) Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341:1351–1357

    CAS  PubMed  Google Scholar 

  153. Evans JM, Ziegler MG, Patwardhan AR, Ott JB, Kim CS, Leonelli FM, Knapp CF (2001) Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. J Appl Physiol 91:2611–2618

    CAS  PubMed  Google Scholar 

  154. Carter JB, Banister EW, Blaber AP (2003) Effect of endurance exercise on autonomic control of heart rate. Sports Med 33:33–46

    PubMed  Google Scholar 

  155. Gulli G, Cevese A, Cappelletto P, Gasparini G, Schena F (2003) Moderate aerobic training improves autonomic cardiovascular control in older women. Clin Auton Res 13:196–202

    PubMed  Google Scholar 

  156. Wang M, Baker L, Tsai BM, Meldrum KK, Meldrum DR (2005) Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 288:E321–E326

    CAS  PubMed  Google Scholar 

  157. Ranki HJ, Budas GR, Crawford RM, Jovanovic A (2001) Gender-specific difference in cardiac ATP-sensitive K(+) channels. J Am Coll Cardiol 38:906–915

    CAS  PubMed  Google Scholar 

  158. Marini M, Lapalombella R, Margonato V, Ronchi R, Samaja M, Scapin C, Gorza L, Maraldi T, Carinci P, Ventura C et al (2007) Mild exercise training, cardioprotection and stress genes profile. Eur J Appl Physiol 99:503–510

    PubMed  Google Scholar 

  159. Brown DA, Chicco AJ, Jew KN, Johnson MS, Lynch JM, Watson PA, Moore RL (2005) Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat. J Physiol 569:913–924

    CAS  PubMed  Google Scholar 

  160. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22:438–442

    CAS  PubMed  Google Scholar 

  161. Voss MR, Stallone JN, Li M, Cornelussen RN, Knuefermann P, Knowlton AA (2003) Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 285:H687–H692

    CAS  PubMed  Google Scholar 

  162. Jackson M (2000) Exercise and oxygen radical production by muscle. In: Sen CP, Packer L, Hanninen O (eds) Handbook of oxidants and antioxidants in exercise. Elsevier B.V, Amsterdam, pp 57–68

    Google Scholar 

  163. Siu PM, Bryner RW, Martyn JK, Alway SE (2004) Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J 18:1150–1152

    CAS  PubMed  Google Scholar 

  164. Hutter JJ, Mestril R, Tam EK, Sievers RE, Dillmann WH, Wolfe CL (1996) Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 94:1408–1411

    CAS  PubMed  Google Scholar 

  165. Mestril R, Chi SH, Sayen MR, O’Reilly K, Dillmann WH (1994) Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Invest 93:759–767

    CAS  PubMed  Google Scholar 

  166. Paroo Z, Haist JV, Karmazyn M, Noble EG (2002) Exercise improves postischemic cardiac function in males but not females: consequences of a novel sex-specific heat shock protein 70 response. Circ Res 90:911–917

    CAS  PubMed  Google Scholar 

  167. Jew KN, Moore RL (2002) Exercise training alters an anoxia-induced, glibenclamide-sensitive current in rat ventricular cardiocytes. J Appl Physiol 92:1473–1479

    PubMed  Google Scholar 

  168. Jew KN, Olsson MC, Mokelke EA, Palmer BM, Moore RL (2001) Endurance training alters outward K + current characteristics in rat cardiocytes. J Appl Physiol 90:1327–1333

    CAS  PubMed  Google Scholar 

  169. Noma A (1983) ATP-regulated K + channels in cardiac muscle. Nature 305:147–148

    CAS  PubMed  Google Scholar 

  170. O’Rourke B (2000) Myocardial K(ATP) channels in preconditioning. Circ Res 87:845–855

    PubMed  Google Scholar 

  171. Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR (2004) Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 287:H841–H849

    CAS  PubMed  Google Scholar 

  172. Yamashita N, Baxter GF, Yellon DM (2001) Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism. Heart 85:331–336

    CAS  PubMed  Google Scholar 

  173. Vondriska TM, Klein JB, Ping P (2001) Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol 280:H1434–H1441

    CAS  PubMed  Google Scholar 

  174. Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, Konhilas JP, Brown DA, Chicco AJ, Sparagna GC, Long CS et al (2007) Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol 293:H246–H259

    CAS  PubMed  Google Scholar 

  175. Dorn JP, Cerny FJ, Epstein LH, Naughton J, Vena JE, Winkelstein W Jr, Schisterman E, Trevisan M (1999) Work and leisure time physical activity and mortality in men and women from a general population sample. Ann Epidemiol 9:366–373

    CAS  PubMed  Google Scholar 

  176. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS (2002) Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347:716–725

    PubMed  Google Scholar 

  177. Gregg EW, Cauley JA, Stone K, Thompson TJ, Bauer DC, Cummings SR, Ensrud KE (2003) Relationship of changes in physical activity and mortality among older women. JAMA 289:2379–2386

    PubMed  Google Scholar 

  178. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM (1997) Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349:1146–1147

    CAS  PubMed  Google Scholar 

  179. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS (1997) Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99:2429–2437

    CAS  PubMed  Google Scholar 

  180. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K et al (1997) Aromatase expression in health and disease. Recent Prog Horm Res 52:185–213, discussion 213–214

    CAS  PubMed  Google Scholar 

  181. Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Bello-Klein A, Singal P (2002) Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz J Med Biol Res 35:1075–1081

    CAS  PubMed  Google Scholar 

  182. Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, Moore RL (2005) Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol 564:619–630

    CAS  PubMed  Google Scholar 

  183. Ranki HJ, Budas GR, Crawford RM, Davies AM, Jovanovic A (2002) 17Beta-estradiol regulates expression of K(ATP) channels in heart-derived H9c2 cells. J Am Coll Cardiol 40:367–374

    CAS  PubMed  Google Scholar 

  184. Nakano M, Sugioka K, Naito I, Takekoshi S, Niki E (1987) Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochem Biophys Res Commun 142:919–924

    CAS  PubMed  Google Scholar 

  185. Tranquilli AL, Mazzanti L, Cugini AM, Cester N, Garzetti GG, Romanini C (1995) Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecol Endocrinol 9:137–141

    CAS  PubMed  Google Scholar 

  186. Suematsu T, Kamada T, Abe H, Kikuchi S, Yagi K (1977) Serum lipoperoxide level in patients suffering from liver diseases. Clin Chim Acta 79:267–270

    CAS  PubMed  Google Scholar 

  187. Akova B, Surmen-Gur E, Gur H, Dirican M, Sarandol E, Kucukoglu S (2001) Exercise-induced oxidative stress and muscle performance in healthy women: role of vitamin E supplementation and endogenous oestradiol. Eur J Appl Physiol 84:141–147

    CAS  PubMed  Google Scholar 

  188. Knopp RH (1988) The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol 72:23S–30S

    CAS  PubMed  Google Scholar 

  189. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA (1993) Cardiovascular protection by oestrogen–a calcium antagonist effect? Lancet 341:1264–1265

    CAS  PubMed  Google Scholar 

  190. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ (1993) Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118:429–432

    CAS  PubMed  Google Scholar 

  191. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A (1995) Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214:847–855

    CAS  PubMed  Google Scholar 

  192. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, Arnal JF (2002) Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 90:413–419

    CAS  PubMed  Google Scholar 

  193. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd (1994) Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786–791

    CAS  PubMed  Google Scholar 

  194. Gilligan DM, Quyyumi AA, Cannon RO 3rd (1994) Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89:2545–2551

    CAS  PubMed  Google Scholar 

  195. Niebauer J, Cooke JP (1996) Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 28:1652–1660

    CAS  PubMed  Google Scholar 

  196. Dimmeler S, Zeiher AM (2003) Exercise and cardiovascular health: get active to “AKTivate” your endothelial nitric oxide synthase. Circulation 107:3118–3120

    PubMed  Google Scholar 

  197. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF et al (2003) Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107:3152–3158

    CAS  PubMed  Google Scholar 

  198. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG (2000) Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 105:1631–1639

    CAS  PubMed  Google Scholar 

  199. Harvey PJ, Picton PE, Su WS, Morris BL, Notarius CF, Floras JS (2005) Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women. Am Heart J 149:291–297

    PubMed  Google Scholar 

  200. Bupha-Intr T, Laosiripisan J, Wattanapermpool J (2009) Moderate intensity of regular exercise improves cardiac SR Ca2+ uptake activity in ovariectomized rats. J Appl Physiol 107:1105–1112

    CAS  PubMed  Google Scholar 

  201. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health Initiative randomized controlled trial. JAMA 288:321–333

    CAS  PubMed  Google Scholar 

  202. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605–613

    CAS  PubMed  Google Scholar 

  203. Ostadal B, Netuka I, Maly J, Besik J, Ostadalova I (2009) Gender differences in cardiac ischemic injury and protection–experimental aspects. Exp Biol Med (Maywood) 234:1011–1019

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by an NIH grant to L.A.L. (NIH HL50560) and to K.K.B.B. (T32 HL-007822). Support was also received from an American Heart Association Postdoctoral Fellowship to P.A.H. (11POST7780011).

Author information

Authors and Affiliations

  1. Department of Molecular, Cellular, and Developmental Biology, BioFrontiers Institute, University of Colorado, Campus Box 347, Boulder, CO, 80309, USA

    Kristen K. B. Barthel Ph.D., Pamela A. Harvey Ph.D. & Leslie A. Leinwand Ph.D.

Authors
  1. Kristen K. B. Barthel Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela A. Harvey Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leslie A. Leinwand Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie A. Leinwand Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Kinesiology, University of Maryland School of Public Health, College Park, Maryland, USA

    Espen E. Spangenburg

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Barthel, K.K.B., Harvey, P.A., Leinwand, L.A. (2013). Diet and Exercise Are Potent Modulators of Cardiovascular Disease in Women. In: Spangenburg, E. (eds) Integrative Biology of Women’s Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8630-5_10

Download citation

Publish with us

Policies and ethics

Search

Navigation